These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 34724318)
1. Improvement in epistaxis management: the experience of a dedicated hereditary haemorrhagic telangiectasia clinic. Anning R; Huang J; Ronan A; de Malmanche J; Asher R; Low TH ANZ J Surg; 2022 Mar; 92(3):499-504. PubMed ID: 34724318 [TBL] [Abstract][Full Text] [Related]
2. Understanding hereditary hemorrhagic telangiectasia: From genetic anomalies to systemic manifestations, quality of life, and epistaxis management-Exploring the otolaryngologist's integral role. Hayama M; Maeda Y; Obata S; Tsuda T; Takeda K; Nishida T; Inohara H Auris Nasus Larynx; 2024 Apr; 51(2):305-312. PubMed ID: 38008660 [TBL] [Abstract][Full Text] [Related]
3. Telangiectasias, recurrent epistaxis and a strong family history-a case of Osler- Weber-Rendu Syndrome in Pakistan. Arif Siddiqui MM; Hafeez T; Din RU J Pak Med Assoc; 2024 Apr; 74(4):800-803. PubMed ID: 38751284 [TBL] [Abstract][Full Text] [Related]
4. Longitudinal Assessment of Curaçao Criteria in Children with Hereditary Hemorrhagic Telangiectasia. Pollak M; Gatt D; Shaw M; Hewko SL; Lamanna A; Santos S; Ratjen F J Pediatr; 2023 Dec; 263():113665. PubMed ID: 37572862 [TBL] [Abstract][Full Text] [Related]
5. Integration of clinical parameters, genotype and epistaxis severity score to guide treatment for hereditary hemorrhagic telangiectasia associated bleeding. Beckman JD; Li Q; Hester ST; Leitner O; Smith KL; Kasthuri RS Orphanet J Rare Dis; 2020 Jul; 15(1):185. PubMed ID: 32660636 [TBL] [Abstract][Full Text] [Related]
6. Hereditary haemorrhagic telangiectasia and pulmonary arteriovenous malformations. Dunphy L; Talwar A; Patel N; Evans A BMJ Case Rep; 2021 Jan; 14(1):. PubMed ID: 33419752 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of Timolol in a Novel Intranasal Thermosensitive Gel for Hereditary Hemorrhagic Telangiectasia-Associated Epistaxis: A Randomized Clinical Trial. Peterson AM; Lee JJ; Kallogjeri D; Schneider JS; Chakinala MM; Piccirillo JF JAMA Otolaryngol Head Neck Surg; 2020 Nov; 146(11):1006-1014. PubMed ID: 32940653 [TBL] [Abstract][Full Text] [Related]
8. [Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu syndrome) Part I. Pathophysiology, clinical symptoms and recommend screening for vascular malformations]. Adam Z; Brančiková D; Romanová G; Pour L; Krejčí M; König J; Nebeský T; Adamová Z; Štork M; Krejčí M; Ševčíková S; Eid M; Král Z Vnitr Lek; 2021; 67(6):339-344. PubMed ID: 35459376 [TBL] [Abstract][Full Text] [Related]
9. The minimal important difference of the epistaxis severity score in hereditary hemorrhagic telangiectasia. Yin LX; Reh DD; Hoag JB; Mitchell SE; Mathai SC; Robinson GM; Merlo CA Laryngoscope; 2016 May; 126(5):1029-32. PubMed ID: 26393959 [TBL] [Abstract][Full Text] [Related]
10. A review on clinical management and pharmacological therapy on hereditary haemorrhagic telangiectasia (HHT). Zarrabeitia R; Albiñana V; Salcedo M; Señaris-Gonzalez B; Fernandez-Forcelledo JL; Botella LM Curr Vasc Pharmacol; 2010 Jul; 8(4):473-81. PubMed ID: 19485912 [TBL] [Abstract][Full Text] [Related]
11. Identification of a Novel ACVRL1 Gene Mutation (c.100T>A, p.Cys34Ser) in a Japanese Patient with Possible Hereditary Hemorrhagic Telangiectasia (Osler-Weber-Rendu Disease). Umemura H; Miura K; Naruse H; Hatta Y; Takei M; Nakayama T Acta Med Okayama; 2020 Apr; 74(2):165-169. PubMed ID: 32341592 [TBL] [Abstract][Full Text] [Related]
12. Medical management of haemorrhagic hereditary telangiectasia in adult patients. Riera-Mestre A; Ribas J; Castellote J Med Clin (Barc); 2019 Apr; 152(7):274-280. PubMed ID: 30502301 [TBL] [Abstract][Full Text] [Related]
14. Correlation of severity of epistaxis with nasal telangiectasias in hereditary hemorrhagic telangiectasia (HHT) patients. Pagella F; Colombo A; Matti E; Giourgos G; Tinelli C; Olivieri C; Danesino C Am J Rhinol Allergy; 2009; 23(1):52-8. PubMed ID: 19379613 [TBL] [Abstract][Full Text] [Related]
15. The use of thalidomide therapy for refractory epistaxis in hereditary haemorrhagic telangiectasia: systematic review. Harrison L; Kundra A; Jervis P J Laryngol Otol; 2018 Oct; 132(10):866-871. PubMed ID: 30191780 [TBL] [Abstract][Full Text] [Related]
16. Silent threat? A retrospective study of screening practices for pulmonary arteriovenous malformations in patients with hereditary haemorrhagic telangiectasia. Verkerk MM; Shovlin CL; Lund VJ Rhinology; 2012 Sep; 50(3):277-83. PubMed ID: 22888484 [TBL] [Abstract][Full Text] [Related]
17. Laser-Assisted Control of Epistaxis in Hereditary Hemorrhagic Telangiectasia: A Systematic Review. Abiri A; Goshtasbi K; Maducdoc M; Sahyouni R; Wang MB; Kuan EC Lasers Surg Med; 2020 Apr; 52(4):293-300. PubMed ID: 31441079 [TBL] [Abstract][Full Text] [Related]
18. The effects of epistaxis on health-related quality of life in patients with hereditary hemorrhagic telangiectasia. Merlo CA; Yin LX; Hoag JB; Mitchell SE; Reh DD Int Forum Allergy Rhinol; 2014 Nov; 4(11):921-5. PubMed ID: 25145809 [TBL] [Abstract][Full Text] [Related]
19. The natural history of epistaxis in patients with hereditary hemorrhagic telangiectasia in the Norwegian population: a cross-sectional study. Dheyauldeen S; Abdelnoor M; Bachmann-Harildstad G Am J Rhinol Allergy; 2011; 25(4):214-8. PubMed ID: 21819756 [TBL] [Abstract][Full Text] [Related]
20. Hereditary haemorrhagic telangiectasia (Osler-Weber-Rendu syndrome): a view from the 21st century. Begbie ME; Wallace GM; Shovlin CL Postgrad Med J; 2003 Jan; 79(927):18-24. PubMed ID: 12566546 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]